MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ipca Laboratories
Ipca Laboratories
BSE: 524494|NSE: IPCALAB|ISIN: INE571A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 24, 17:00
570.70
-7.55 (-1.31%)
VOLUME 3,320
LIVE
NSE
May 24, 17:00
572.80
-3.85 (-0.67%)
VOLUME 59,167
News on Ipca Laboratories
Select Year: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Buy Syndicate Bank, Ipca Labs, Jain Irrigation: Mukadam 

5.05 pm | 16 May 2013 |  Source: CNBC-TV18

Shahina Mukadam of Varun Capital has recommended buy rating on Syndicate Bank, Ipca Laboratories, Jain Irrigation and Tata Global Beverages....

Hold Ipca Laboratories: Pankaj Jain 

3.46 pm | 15 May 2013 |  Source: CNBC-TV18

Ipca Laboratories is doing exceedingly well on all fronts. The company has a very strong research and development (R&D) department, so one should hold...

Nifty may climb another 200; bullish on midcaps: Motilal 

5.50 pm | 07 May 2013 |  Source: CNBC-TV18

Today, dated May 7 the Nifty rallied above 6000 to its highest levels since February 4, 2013. Gautam Sinha Roy, Motilal Oswal Securities expects anoth...

Bullish on Glenmark, Ipca Labs among midcaps: Antique 

3.14 pm | 07 May 2013 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Anmol Ganjoo of Antique Broking share outlook on the pharmaceutical space and trading strategies for various stocks in t...

Ipca Laboratories FY13 results on May 30, 2013

11.55 am | 06 May 2013 |  Source: Moneycontrol.com

Ipca Laboratories board meeting will be held on May 30, 2013, to consider the Audited Financial Results for the financial year ended March 31, 2013 an...

What stocks you should buy/avoid coming week?

4.54 pm | 28 Apr 2013 |  Source: Moneycontrol.com

Manoj Sachdeva, Research Head of Hem Securities teams up with Moneycontrol.com to answer investor queries....

Pharma cos likely to post 21% EBITDA growth in Q4: MOST

1.30 pm | 16 Apr 2013 |  Source: Moneycontrol.com

Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY a...

Buy IPCA Laboratories; target Rs 581: Firstcall Research

12.02 pm | 20 Mar 2013 |  Source: Moneycontrol.com

Firstcall Research is bullish on IPCA Laboratories and has recommended buy rating on the stock with a target price of Rs 581 in its March 18, 2013 res...

Accumulate Ipca Laboratories; target Rs 572: Dolat Capital

7.08 pm | 13 Mar 2013 |  Source: Moneycontrol.com

Dolat Capital is bullish on Ipca Laboratories and has recommended accumulate rating on the stock with a target price of Rs 572 in its March 11, 2013 r...

Buy Ipca Labs; target of Rs 645: Motilal Oswal

11.43 am | 05 Feb 2013 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 645 in its February 1, 2013 research rep...

Improvement in gross margins likely to continue: Ipca Labs 

1.11 pm | 04 Feb 2013 |  Source: CNBC-TV18

Last week, Ipca Laboratories reported net profit of Rs 87.89 crore for the quarter ending December 31, 2012 on the back of strong sales across domesti...

Accumulate Ipca Labs; target of Rs 572: Dolat Capital

1.35 pm | 01 Feb 2013 |  Source: Moneycontrol.com

Dolat Capital is bullish on Ipca Laboratories and has recommended accumulate rating on the stock with a target of Rs 572 in its January 31, 2013 resea...

Buy Ipca Laboratories; target of Rs 559: Angel Broking

1.23 pm | 01 Feb 2013 |  Source: Moneycontrol.com

Angel Broking is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 559 in its January 30, 2013 research rep...

Ipca Labs standalone Dec '12 sales at Rs 701.02 crore

5.04 pm | 31 Jan 2013 |  Source: Moneycontrol.com

Ipca Laboratories has reported a sales standalone turnover of Rs 701.02 crore and a net profit of Rs 87.89 crore for the quarter ended Dec '12...

Buy Ipca Laboratories; target Rs 710: P Lilladher

1.35 pm | 31 Jan 2013 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Ipca Laboratories (Ipca) and has recommended buy rating on the stock with a target price of Rs 710 in its January 31...

Good performance likely from pharma in Q3: Nirmal Bang

3.52 pm | 12 Jan 2013 |  Source: Moneycontrol.com

Nirmal Bang has come out with its earnings estimates for pharmaceutical sector for the quarter ended December 2012. The research firm feels margins of...

See pharma sector's Q3 topline to grow 22%: Motilal Oswal

11.54 am | 12 Jan 2013 |  Source: Moneycontrol.com

Motilal Oswal has come out with its earnings estimates for pharmaceuticals sector for the quarter ended December 2012. The research firm expects the t...

See pharma sector's Q3 adj PAT to grow 26% YoY: P Lilladher

10.57 am | 12 Jan 2013 |  Source: Moneycontrol.com

Prabhudas Lilladher has come out with its earnings estimates for pharmaceuticals sector for the quarter ended December 2012. The research firm expects...

See pharma sector's margins to dip 314 bps in 3QFY13: Angel

5.10 pm | 08 Jan 2013 |  Source: Moneycontrol.com

Angel Broking has come out with earning expectations for pharmaceutical sector for the October-December quarter of 2012. The research firm expects the...

Buy Ipca Laboratories; target of Rs 641: Nirmal Bang

12.15 pm | 01 Jan 2013 |  Source: Moneycontrol.com

Nirmal Bang is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 641 in its December 31, 2012 research repo...

1 2
Quick Links for Ipca Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.